0001507673-20-000002.txt : 20200214 0001507673-20-000002.hdr.sgml : 20200214 20200213191450 ACCESSION NUMBER: 0001507673-20-000002 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20191231 FILED AS OF DATE: 20200214 DATE AS OF CHANGE: 20200213 EFFECTIVENESS DATE: 20200214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RP Management, LLC CENTRAL INDEX KEY: 0001507673 IRS NUMBER: 611450238 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-19261 FILM NUMBER: 20612889 BUSINESS ADDRESS: STREET 1: 110 EAST 59TH STREET STREET 2: SUITE 3300 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-883-0200 MAIL ADDRESS: STREET 1: 110 EAST 59TH STREET STREET 2: SUITE 3300 CITY: NEW YORK STATE: NY ZIP: 10022 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001507673 XXXXXXXX 12-31-2019 12-31-2019 RP Management, LLC
110 East 59th Street Suite 3300 New York NY 10022
13F HOLDINGS REPORT 028-19261 N
Jason Mehar Vice President, Investments & Deputy General Counsel 2128832271 /s/ Jason Mehar New York NY 02-13-2020 1 6 442294 false 1 0001507678 028-19630 Legorreta Pablo G.
INFORMATION TABLE 2 a13f2019q4draftinformation.xml INFORMATION TABLE CYTOKINETICS INC COM NEW 23282W605 9291 875656 SH DFND 1 875656 0 0 IMMUNOMEDICS INC COM 452907108 92536 4373178 SH DFND 1 4373178 0 0 BIOHAVEN PHARMACTL HLDG CO L COM G11196105 114923 2111111 SH DFND 1 2111111 0 0 SUNESIS PHARMACEUTICALS INC COM 867328700 44 129517 SH DFND 1 129517 0 0 EPIZYME INC COM 29428V104 164000 6666667 SH DFND 1 6666667 0 0 EPIZYME INC COM 29428V904 61500 2500000 SH Call DFND 1 2500000 0 0